The ethics of clinical innovation in psychopharmacology: Challenging traditional bioethics
2007

The Ethics of Clinical Innovation in Psychopharmacology

publication Evidence: low

Author Information

Author(s): S. Nassir Ghaemi, Frederick K. Goodwin

Primary Institution: Emory University School of Medicine

Hypothesis

What is the ethical basis for clinical innovation in psychopharmacology?

Conclusion

Clinical innovation is necessary for progress in psychopharmacology and should be guided by ethical principles.

Supporting Evidence

  • Clinical innovation has historically contributed to progress in psychopharmacology.
  • Many new medications in psychiatry have originated from clinical innovation.
  • Ethical guidelines for clinical innovation can help balance patient welfare and knowledge advancement.

Takeaway

Doctors can try new treatments that haven't been fully tested yet, but they need to be careful and follow certain rules to keep patients safe.

Methodology

A literature review utilizing MEDLINE search and bibliographic cross-referencing.

Potential Biases

The separation of clinical practice from research may lead to uncontrolled clinical innovation.

Limitations

Empirical data regarding the impact of clinical innovation in psychopharmacology are lacking.

Digital Object Identifier (DOI)

10.1186/1747-5341-2-26

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication